Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Negrier

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 19, 2018
Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensusAxel Seuser, Claudia Djambas Khayat, Claude Negrier, et al.
Expert Review of Hematology|April 4, 2013
Factor XI and traveling waves: the key to understanding coagulation in hemophilia?Fazoil I Ataullakhanov, Natalia M Dashkevich, Claude Negrier, et al.
Patient Preference and Adherence|June 16, 2022
The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-MakingMichael Wang, Claude Negrier, Frank Driessler, et al.
Haematologica|June 21, 2006
A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drugYesim Dargaud, Jean Claude Bordet, Marie C Trzeciak, et al.
Thrombosis and Haemostasis|November 3, 2006
Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotypeYesim Dargaud, M Christine Trzeciak, Jean Claude Bordet, et al.
Haematologica|February 24, 2018
Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumabYesim Dargaud, Anne Lienhart, Maissaa Janbain, et al.
Blood|September 28, 2002
Skewed X-chromosome inactivation in monochorionic diamniotic twin sisters results in severe and mild hemophilia ASophie Valleix, Christine Vinciguerra, Jean-Maurice Lavergne, et al.
Thrombosis and Haemostasis|November 20, 2018
Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IXSandra Le Quellec, Nathalie Enjolras, Eloïse Perot, et al.
Thrombosis Research|September 27, 2005
Inherited bleeding disorder due to familial type 2 platelet cyclo-oxygenase deficiencyYesim Dargaud, Jean C Bordet, Marie C Trzeciak, et al.
Blood|January 16, 2013
Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectivesGuy Young, Benny Sørensen, Yesim Dargaud, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 19, 2018
Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensusAxel Seuser, Claudia Djambas Khayat, Claude Negrier, et al.
Expert Review of Hematology|April 4, 2013
Factor XI and traveling waves: the key to understanding coagulation in hemophilia?Fazoil I Ataullakhanov, Natalia M Dashkevich, Claude Negrier, et al.
Patient Preference and Adherence|June 16, 2022
The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-MakingMichael Wang, Claude Negrier, Frank Driessler, et al.
Haematologica|June 21, 2006
A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drugYesim Dargaud, Jean Claude Bordet, Marie C Trzeciak, et al.
Thrombosis and Haemostasis|November 3, 2006
Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotypeYesim Dargaud, M Christine Trzeciak, Jean Claude Bordet, et al.
Haematologica|February 24, 2018
Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumabYesim Dargaud, Anne Lienhart, Maissaa Janbain, et al.
Blood|September 28, 2002
Skewed X-chromosome inactivation in monochorionic diamniotic twin sisters results in severe and mild hemophilia ASophie Valleix, Christine Vinciguerra, Jean-Maurice Lavergne, et al.
Thrombosis and Haemostasis|November 20, 2018
Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IXSandra Le Quellec, Nathalie Enjolras, Eloïse Perot, et al.
Thrombosis Research|September 27, 2005
Inherited bleeding disorder due to familial type 2 platelet cyclo-oxygenase deficiencyYesim Dargaud, Jean C Bordet, Marie C Trzeciak, et al.
Blood|January 16, 2013
Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectivesGuy Young, Benny Sørensen, Yesim Dargaud, et al.
Pageof 7